ARQT · Arcutis Biotherapeutics, Inc. · Documents
$31.87
-0.95 (-2.89%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$3.99B
Shares
125.69M
Volume · Oct 21
1.69M
Avg daily vol (3M)
2.4M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| SC TO-I/A | — | 2024-01-24 | — | |
| SC TO-I | — | 2024-01-16 | — | |
| SC TO-C | — | 2024-01-11 | — | |
| 8-K | — | 2024-01-11 | — | |
| 8-K | — | 2023-12-18 | 2023-12-15 | |
| 10-Q | — | 2023-11-03 | 2023-09-30 | |
| 8-K | — | 2023-11-03 | — | |
| 8-K | — | 2023-10-23 | 2023-10-19 | |
| 8-K | — | 2023-10-19 | — | |
| 8-K | — | 2023-09-27 | — | |
| 10-Q/A | — | 2023-09-15 | 2023-03-31 | |
| 10-Q/A | — | 2023-09-15 | 2023-06-30 | |
| 10-K/A | — | 2023-09-15 | 2022-12-31 | |
| 8-K/A | — | 2023-09-07 | 2023-08-15 | |
| 8-K | — | 2023-08-18 | 2023-08-15 | |
| 8-K | — | 2023-08-14 | 2023-08-10 | |
| 8-K | — | 2023-08-08 | — | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-06-05 | 2023-06-02 | |
| 8-K | — | 2023-05-24 | 2023-05-22 | |
| 8-K | — | 2023-05-09 | — | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| DEFA14A | — | 2023-04-18 | — | |
| DEF 14A | — | 2023-04-18 | — | |
| 8-K | — | 2023-02-28 | — | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2022-12-16 | 2022-12-12 | |
| 8-K | — | 2022-11-08 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-09-07 | — | |
| 8-K | — | 2022-09-06 | 2022-09-02 | |
| 8-K | — | 2022-08-05 | 2022-08-02 | |
| 8-K | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-08-02 | 2022-07-29 | |
| 8-K | — | 2022-06-09 | 2022-06-06 | |
| 8-K | — | 2022-06-02 | 2022-06-01 | |
| 8-K | — | 2022-05-05 | — | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| DEFA14A | — | 2022-04-19 | — | |
| DEF 14A | — | 2022-04-19 | 2022-06-01 | |
| 10-K/A | — | 2022-03-03 | 2021-12-31 | |
| 10-K | — | 2022-02-22 | 2021-12-31 | |
| 8-K | — | 2022-02-22 | — | |
| 8-K | — | 2021-12-23 | 2021-12-22 | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-11-04 | — | |
| 8-K | — | 2021-10-04 | — | |
| 8-K | — | 2021-09-28 | 2021-09-22 | |
| 8-K | — | 2021-09-07 | 2021-09-03 |
Showing 51–100 of 134 filings
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
33 filings
33 filers
Visit website
Investor relations